Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Differin gel to be launched in Japan for topical treatment of acne vulgaris

Oct. 15, 2008

Revotar presents phase I data for bimosiamose 5% cream in psoriasis

Oct. 14, 2008

Avontec reports results of phase IIa AVT-02 trial in psoriasis

Oct. 14, 2008

Results disclosed from PHOENIX 2 phase III study with ustekinumab in psoriasis

Oct. 13, 2008

P144 TGF-beta1 inhibitor safe in phase I study in healthy volunteers

Oct. 10, 2008

Biofrontera completes treatment and evaluation in phase III BF-200 ALA trial

Oct. 10, 2008

Incyte reports safety and efficacy for INCB-018424 in proof-of-concept psoriasis study

Oct. 9, 2008

EMEA withdraws marketing authorization for Protopy in the European Union

Oct. 9, 2008

K-301 found safe and efficacious in scalp seborrheic dermatitis

Oct. 8, 2008

Genentech reports case of PML in patient who received Raptiva for more than 4 years

Oct. 7, 2008

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...